4.7 Article

Twenty-five-year trajectories of insulin resistance and pancreatic beta-cell response and diabetes risk in nonalcoholic fatty liver disease

Journal

LIVER INTERNATIONAL
Volume 38, Issue 11, Pages 2069-2081

Publisher

WILEY
DOI: 10.1111/liv.13747

Keywords

coronary artery risk development in young adults; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; obesity

Funding

  1. National Institutes of Health (NIH) [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C, AG0005]
  2. NIH [KL2TR001424, T32HL069771, R01HL098445]
  3. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001424, KL2TR000107] Funding Source: NIH RePORTER
  4. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL136891, T32HL069771] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107904] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Background & Aims Insulin resistance is a risk marker for non-alcoholic fatty liver disease, and a risk factor for liver disease progression. We assessed temporal trajectories of insulin resistance and -cell response to serum glucose concentration throughout adulthood and their association with diabetes risk in non-alcoholic fatty liver disease. MethodsResultsThree thousand and sixty participants from Coronary Artery Risk Development in Young Adults, a prospective bi-racial cohort of adults age 18-30years at baseline (1985-1986; Y0) who completed up to 5 exams over 25years and had fasting insulin and glucose measurement were included. At Y25 (2010-2011), non-alcoholic fatty liver disease was assessed by noncontrast computed tomography after exclusion of other liver fat causes. Latent mixture modelling identified 25-year trajectories in homeostatic model assessment insulin resistance and -cell response homeostatic model assessment-. Three distinct trajectories were identified, separately, for homeostatic model assessment insulin resistance (low-stable [47%]; moderate-increasing [42%]; and high-increasing [12%]) and homeostatic model assessment- (low-decreasing [16%]; moderate-decreasing [63%]; and high-decreasing [21%]). Y25 non-alcoholic fatty liver disease prevalence was 24.5%. Among non-alcoholic fatty liver disease, high-increasing homeostatic model assessment insulin resistance (referent: low-stable) was associated with greater prevalent (OR 95% CI=8.0, 2.0-31.9) and incident (OR=10.5, 2.6-32.8) diabetes after multivariable adjustment including Y0 or Y25 homeostatic model assessment insulin resistance. In contrast, non-alcoholic fatty liver disease participants with low-decreasing homeostatic model assessment- (referent: high-decreasing) had the highest odds of prevalent (OR=14.1, 3.9-50.9) and incident (OR=10.3, 2.7-39.3) diabetes. ConclusionTrajectories of insulin resistance and -cell response during young and middle adulthood are robustly associated with diabetes risk in non-alcoholic fatty liver disease. Thus, how persons with non-alcoholic fatty liver disease develop resistance to insulin provides important information about risk of diabetes in midlife above and beyond degree of insulin resistance at the time of non-alcoholic fatty liver disease assessment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available